Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceutical Ingredient Manufactured by Solara Active Pharma Scien

Read also

From Patent to Patient

From Patent to Patient: FDA Policy Ideas to Protect and Speed Medical Innovation

Genmab

Genmab to acquire Merus shares for $8bn

Climb Bio

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN

Mytesi Seeks FDA

Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea